Lupin Pharmaceuticals
There is only one reason why we exist — to treat diseases, to heal and enrich human life.
There is only one reason why we exist — to treat diseases, to heal and enrich human life.
Lupin Pharmaceuticals, founded in 2003, is a subsidiary of Lupin Limited, a leading Indian pharmaceutical company. With its headquarters in the United States, the company is committed to providing high-quality branded and generic medications to healthcare professionals and patients globally. Lupin's mission, encapsulated in the slogan "There is only one reason why we exist — to treat diseases, to heal and enrich human life.", reflects its dedication to improving human health. The company received a significant post-IPO equity investment on 01 September 2013 from Baring Private Equity India, highlighting its appeal to investors and potential for growth. Lupin's presence in the Biotechnology, Manufacturing, and Pharmaceutical industries positions it well for further expansion and innovation.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | Unknown | 1 | Baring Private Equity India | 01 Sep 2013 |
No recent news or press coverage available for Lupin Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.
